➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Boehringer Ingelheim
Express Scripts
Medtronic
Mallinckrodt

Last Updated: August 2, 2021

DrugPatentWatch Database Preview

TETRACYCLINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Tetracycline Hydrochloride patents expire, and what generic alternatives are available?

Tetracycline Hydrochloride is a drug marketed by Abbott, Amneal Pharms Ny, Ani Pharms, Breckenridge, Chartwell Tetra, Elkins Sinn, Ferrante, Heather, Hikma, Impax Labs, Ivax Sub Teva Pharms, Mast Mm, Mylan, Purepac Pharm, Pvt Form, Roxane, Strides Pharma, Sun Pharm Industries, Superpharm, Valeant Pharm Intl, Warner Chilcott, Watson Labs, Wyeth Ayerst, Alpharma Us Pharms, and Proter. and is included in twenty-nine NDAs.

The generic ingredient in TETRACYCLINE HYDROCHLORIDE is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tetracycline Hydrochloride

A generic version of TETRACYCLINE HYDROCHLORIDE was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.

  Free Forever Trial

Summary for TETRACYCLINE HYDROCHLORIDE
Drug patent expirations by year for TETRACYCLINE HYDROCHLORIDE

US Patents and Regulatory Information for TETRACYCLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 062103-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Sun Pharm Industries TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 060736-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Ferrante TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride SUSPENSION;ORAL 060174-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Watson Labs TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 062343-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Boehringer Ingelheim
Express Scripts
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.